Who are morphine ,ketorolac's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): hydrochloride hydromorphone + flurbiprofen axetil.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/morphine-ketorolac.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

morphine ,ketorolac — Competitive Intelligence Brief

morphine ,ketorolac (morphine ,ketorolac) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid analgesic + NSAID combination. Area: Pain Management.

marketed Opioid analgesic + NSAID combination Opioid receptors (μ, δ, κ); COX-1 and COX-2 enzymes Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

morphine ,ketorolac (morphine ,ketorolac) — Jose Antonio Bernia Gil. This is a combination of morphine (an opioid agonist) and ketorolac (an NSAID) that work together to provide analgesia through different pathways.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
morphine ,ketorolac TARGET	morphine ,ketorolac	Jose Antonio Bernia Gil	marketed	Opioid analgesic + NSAID combination	Opioid receptors (μ, δ, κ); COX-1 and COX-2 enzymes
hydrochloride hydromorphone + flurbiprofen axetil	hydrochloride hydromorphone + flurbiprofen axetil	First Affiliated Hospital, Sun Yat-Sen University	marketed	Opioid analgesic + NSAID combination	Mu-opioid receptor (hydromorphone); COX-1/COX-2 (flurbiprofen axetil)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid analgesic + NSAID combination class)

First Affiliated Hospital, Sun Yat-Sen University · 1 drug in this class
Jose Antonio Bernia Gil · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). morphine ,ketorolac — Competitive Intelligence Brief. https://druglandscape.com/ci/morphine-ketorolac. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab